Benzinga's Top #PreMarket Gainers

Revance Therapeutics Inc RVNC shares surged 49.79 percent to $40.04 in pre-market trading after the company announced positive 6-month duration in BELMONT study. Cellectis SA (ADR) CLLS shares climbed 11.47 percent to $27.80 in pre-market trading after the company reported successful GMP production process for UCART19. Allergan PLC AGN shares rose 10.38 percent to $317.00 in pre-market trading following Wednesday's Wall Street Journal report on potential merger with Pfizer Inc. PFE. SunPower Corporation SPWR shares rose 6.62 percent to $26.25 in pre-market trading after the company reported strong Q3 results. Vertex Pharmaceuticals Incorporated VRTX gained 5.31 percent to $126.48 in pre-market trading on upbeat Q3 results.